and CIN 3 or worse (CIN 3+, excluding CIN 2). According to the 2009 KPNC cervical cancer screening guidelines, ECC is recommended in all colposcopies in nonpregnant women unless prevented by ...

Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Diagnosed with stage 2 cervical cancer, Louise was horrified to discover her 2016 smear had been misreported, missing high-grade changes. "It came as a huge shock when I found out that I had ...

[2] compared 37 women with low-grade cytological finding and CIN ... In addition, the KPNC cervical cancer screening database is the largest in the United States. We were not able to assess ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

Nurses on Vancouver Island will be heading to schools soon to offer a vaccine to grade 11 and 12 students ... common types of HPV that can cause cervical cancer, other cancers, and genital ...